SECsense Logo

Mangoceuticals, Inc. 8-K Report: Key Insights and Financial Snapshot (Feb 7, 2025)

$MGRX
Form 8-K
Filed on: 2025-02-12
Source
Mangoceuticals, Inc. 8-K Report: Key Insights and Financial Snapshot (Feb 7, 2025)

Based on the provided XML section from the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Mangoceuticals, Inc.
  • CIK (Central Index Key): 0001938046
  • Location: 15110 N. Dallas Parkway, Suite 600, Dallas, TX 75248
  • Phone Number: (214) 242-9619
  • State of Incorporation: Texas
  • SEC File Number: 001-41615
  • Employer Identification Number (EIN): 87-3841292
  1. Filing Type:
  • Form Type: 8-K (This form is used to report major events that shareholders should know about.)
  1. Filing Date:
  • Date of Filing: February 7, 2025
  1. Stock Information:
  • Common Stock: The company has issued common stock with a par value of $0.0001 per share.
  • Ticker Symbol: MGRX
  • Exchange: NASDAQ
  1. Reporting Context:
  • Report Date: The reporting period starts and ends on February 7, 2025, indicating this is likely a snapshot or event report as of that date.
  1. Units of Measurement:
  • Currency Unit: USD (United States Dollar)
  • Shares Unit: Shares

Insights:

  • The report is an 8-K filing, which typically suggests that Mangoceuticals, Inc. may have had a significant event or development requiring disclosure to investors.
  • The document indicates that it provides financial data relevant to the entity's common stock, which is traded on NASDAQ under the ticker MGRX.
  • The par value of the common stock is notably low ($0.0001), which can be indicative of the company's growth stage or capital structure.
  • The information is presented in a structured XBRL format, facilitating automated analysis by financial systems.

This analysis provides a foundational understanding of Mangoceuticals, Inc. as of February 7, 2025, and highlights crucial elements pertinent to investors and stakeholders.